Phase II Trial of Ixabepilone Administered Daily for Five Days in Children and Young Adults with Refractory Solid Tumors: A Report from the Children's Oncology Group

Authors

S Jacobs
E Fox
M Krailo
G Hartley
F Navid

Document Type

Journal Article

Publication Date

2010

Journal

Clinical Cancer Research

Volume

16

Issue

2

Inclusive Pages

750-754

APA Citation

Jacobs, S., Fox, E., Krailo, M., Hartley, G., & Navid, F. (2010). Phase II Trial of Ixabepilone Administered Daily for Five Days in Children and Young Adults with Refractory Solid Tumors: A Report from the Children's Oncology Group. Clinical Cancer Research, 16 (2). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/5374